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In the diagnosis of current gonorrhoea the sensitivity of the gonococcal antibody test was far superior to that of the gonococcal complement fixation test (about 55% versus 9% for first episode gonorrhoea).
To evaluate the usefulness of the test result the following population groups were studied: 1376 patients undergoing medical examination for gonorrhoea (386 had gonorrhoea), 1384 healthy people aged 15-65, 54 patients with meningococcal disease, 30 children with respiratory tract infection, and 254 patients with evidence of various diseases other than neisserial infections that might be associated with symptoms of arthritis. These investigations showed that (1) non-specific positive gonococcal antibody test results occur rarely, (2) at least half the people who have had gonorrhoea remain seropositive (with titres of 1/40 to 1/160), and (3) a positive test result is more significant the younger the patient and the higher the titre. For younger people a positive test result should always be followed up by bacteriological examination; in all age groups titres of 1/320 or more should indicate medical examination for current gonorrhoea. At The test was performed as described previously.67 The highest serum concentration was 1/20. Serum was diluted two fold from a dilution of 1/20. Titres of 1/40 were considered to show positive test results.
GONOCOCCAL COMPLEMENT FIXATION TEST AND MENINGOCOCCAL COMPLEMENT FIXATION TEST
The antigens were prepared and the tests performed as described by Reyn.`The highest serum concentration tested was 1/12. The titre was read as the lowest serum concentration giving 60% haemolysis.
STATISTICAL METHODS
Sensitivity, specificity, and the, predictive value of positive and negative test results were defined as described by Vecchio.`2
Results
Promising preliminary results in evaluating the gonococcal antibody test for diagnosing gonorrhoea67 were achieved when only one highly skilled technician performed the test. To adapt the method to semiautomatic performance, and to train technicians to perform the test routinely, we obtained sera from 727 patients attending a venereological outpatient clinic. The results were similar to those found earlier7; few (8% (2/25) to 11 % (9/85)) patients with current gonorrhoea were seropositive in the gonococcal complement fixation test, whereas most (51% (24/47) to 88% (22/25)) 'were seropositive in the gonococcal antibody (indirect haemagglutination) test (table 1) . A 58% specificity of the gonococcal antibody test means that 42% (221) of 526 patients without current gonorrhoea were found to be seropositive; 53% (266/504) of men and 38% (85/223) of women studied gave histories of gonorrhoea. Tables 2 and 3 show concentrations of antibodies in the 1376 patients examined for gonorrhoea. Table  2 shows that 47% (47) of 101 men and 61% (71) of 116 women wit'l first episode gonorrhoea were seropositive, and 10% of the men and 16% of the women in this group had titres of 1/320 or more. Of patients with current gonorrhoea who had previously had gonorrhoea, 92% (36/39) of women and 79% (102/130) of men were seropositive; and 44% of the women and 25% of the men in this group had titres of 1/320 or more. Table 3 shows the concentrations of antibodies in sera from the 990 patients who did not have gonorrhoea at the time of examination. Of the 557 who had no history of gonorrhoea, 21% (114) were seropositive and 3% had titres of 1/320 or more. Of the 433 who had a history of gonorrhoea, 47% (205) were seropositive. Fig 1 shows the yearly numbers of reported cases of gonorrhoea in Denmark from 1900; 10-25% of people born before 1960 had gonorrhoea at least once. We calculated the incidence of seropositive people as a percentage of those born in any year on the assumption that 30%, 40%, 50%, or 60% of patients with gonorrhoea remain seropositive (fig 2) . The calculations were based on the following data and assumptions: (1) the yearly number of cases of gonorrhoea reported, (2) number of people born in a particular year who were alive when aged 15, (3) that all cases notified a year were new cases (which means that the number of unreported cases was considered
Reimann, Odum, Larsen, Lind were often for patients of 40 or older with arthralgia, Table 4 shows the concentrations of gonococcal we also tested sera from patients with evidence of varantibodies obtained by testing sera from 1384 people ious diseases that might be associated with symptoms (table  5) . There was no indication that cross reacting antibodies are induced in people with these conditions.
Discussion
In the developed countries excellent facilities for bacteriological diagnosis of gonorrhoea exist in many places. Procedures to show gonococcal antibodies are still of interest, however, because culture is unreliable when patients have received antibiotics before being examined and in patients with pelvic inflammatory disease or other manifestations of disseminated gonococcal infection.
In the diagnosis of acute infection the gonococcal antibody test was found to be much more sensitive than the gonococcal complement fixation test and at least as sensitive as serological tests investigated by others,5 [13] [14] [15] though 46% of patients attending STD clinics with first episode gonorrhoea were seronegative. If a serological test is to be used to detect cases of current gonorrhoea in an unselected population, Galen and Gambino16 claim that the minimum requirements of the test should be: (1) sensitivity greater than 80%, (2) specificity greater than 99%, and (3) the ability to differentiate current from past infection. So far, no test to show gonococcal antibodies fulfills all these conditions. [17] [18] [19] The specificity of serological tests to diagnose gonorrhoea depends firstly on the availability of a gonococcal antigen that is unrelated to antigens of other micro-organisms, especially those associated with other sexually transmissible diseases and with diseases that have symptoms similar to those of disseminated gonococcal infection. We found no evidence that non-specific positive gonococcal antibody test results occur in these conditions. Seroconversion (from negative to titres of 1/40 to 1/160) has, however, been noted in a few patients with meningococcal disease. About half the patients without current gonorrhoea who had a history of gonorrhoea were seropositive. This finding prompted us to investigate the antibody status of the general population. We found that 8% (116/1384) were seropositive. In Denmark 10-25% of people born between 1900 and 1960 have had gonorrhoea. Thus it could be concluded that 40-50% of men and more than 60% of women who contract gonorrhoea remain seropositive, presumably for life. The test of choice for diagnosing current gonorrhoea is therefore still culture. Furthermore, culture is always recommended to confirm the diagnosis when gonorrhoea is suspected on the basis of a positive gonococcal antibody test result. The use of serology as the only diagnostic tool should be limited to patients whose case history and clinical picture are consistent with gonococcal infection and for whom the reliability of diagnosis by culture is low.
Judging from numerous telephone conversations with doctors from all over the country during the past six years, it must frankly be admitted that the gonococcal antibody test is used in an unsatisfactory way. Knowledge of the use of serology and how to interpret serological test results seems to be difficult to achieve. Beebe investigated the use of a gonococcal antibody screening test by doctors in New Jersey.20 Despite a thorough bulletin, stressing target groups and the proper use and interpretation of the test, being enclosed with each kit, the doctors used the test on patient groups other than those recommended, and the test results were interpreted as one would interpret the results of culture. They did not realise that the test results are likely to be negative in the early stages of infection and that antibody to Ngonorrhoeae is usually long lived, even after successful treatment.
Our conclusion, after six years of experience with the gonococcal antibody test is that the test is quick and easy to perform, fairly sensitive, and superior in specificity, but its usefulness is hampered by the
